Antiretroviral drug resistance and routine therapy, Cameroon

被引：25
|
作者：
Laurent, C [1 ]
Kouanfack, C
Vergne, L
Tardy, M
Zekeng, L
Noumsi, N
Butel, C
Bourgeois, A
Mpoudi-Ngolé, E
Koulla-Shiro, S
Peeters, M
Delaporte, E
机构：
[1] Inst Rech Dev, UMR 145, Montpellier, France
[2] Cent Hosp, Yaounde, Cameroon
[3] Lab Sante Hyg Mobile, Yaounde, Cameroon
[4] Natl AIDS Program, Yaounde, Cameroon
[5] Mil Hosp, Yaounde, Cameroon
来源：
EMERGING INFECTIOUS DISEASES | 2006年 / 12卷 / 06期
关键词：
D O I：
10.3201/eid1206.050860
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 16.4% had drug resistance after a median of 10 months. Of these, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 10.2% to non-NRTIs, and 2.3% to protease inhibitors.
引用
收藏
页码：1001 / 1004
页数：4
相关论文
共 50 条
  • [1] Virological outcome and antiretroviral drug resistance in the national antiretroviral therapy program in Cameroon
    Montavon, C.
    Kouanfack, C.
    Laurent, C.
    Aghokeng, A.
    Kenfack, A.
    Bourgeois, A.
    Koulla-Shiro, S.
    Delaporte, E.
    Mpoudi-Ngole, E.
    Peeters, M.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A158 - A158
  • [2] Resistance to antiretroviral drug therapy
    Molla, A
    Kohlbrenner, WE
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32, 1997, 32 : 131 - 140
  • [3] Drug resistance in antiretroviral therapy of HIV infection
    Oette, M
    Häussinger, D
    [J]. MEDIZINISCHE KLINIK, 2003, 98 (12): : 692 - 699
  • [4] Antiretroviral therapy in public and private routine health care clinics in Cameroon:: Lessons from the Douala antiretroviral (DARVIR) initiative
    Laurent, C
    Meilo, H
    Guiard-Schmid, JB
    Mapouré, Y
    Noël, JM
    M'Bangué, M
    Joko, A
    Rozenbaum, W
    Ntoné, FN
    Delaporte, E
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (01) : 108 - 111
  • [5] Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon
    Aghokeng, Avelin F.
    Kouanfack, Charles
    Eymard-Duvernay, Sabrina
    Butel, Christelle
    Edoul, Ginette E.
    Laurent, Christian
    Koulla-Shiro, Sinata
    Delaporte, Eric
    Mpoudi-Ngole, Eitel
    Peeters, Martine
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2013, 16
  • [6] Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon
    Meresse, M.
    March, L.
    Kouanfack, C.
    Bonono, R-C
    Boyer, S.
    Laborde-Balen, G.
    Aghokeng, A.
    Suzan-Monti, M.
    Delaporte, E.
    Spire, B.
    Carrieri, M-P
    Laurent, C.
    [J]. HIV MEDICINE, 2014, 15 (08) : 478 - 487
  • [7] Risk of development of drug resistance in patients starting antiretroviral therapy with three or more drugs in routine clinical practice
    Phillips, AN
    Dunn, D
    Sabin, C
    Pozniak, A
    Matthias, R
    Geretti, AM
    Clarke, J
    Churchill, D
    Williams, I
    Hill, T
    Green, H
    Porter, K
    Scullard, G
    Johnson, M
    Easterbrook, P
    Gilson, R
    Fisher, M
    Loveday, C
    Gazzard, B
    Pillay, D
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : U107 - U107
  • [8] Monitoring of antiretroviral therapy: Drug monitoring and resistance determination
    Fatkenheuer, G
    [J]. MEDIZINISCHE WELT, 1998, 49 : 36 - 38
  • [9] Paradoxes of adherence and drug resistance to HIV antiretroviral therapy
    Bangsberg, DR
    Moss, AR
    Deeks, SG
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) : 696 - 699
  • [10] Targeting HIV:: antiretroviral therapy and development of drug resistance
    Menéndez-Arias, L
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (08) : 381 - 388
12345